Introduction
The common cough often makes no alarm at all, especially when it comes to determining the causes or the risks that come with it. However, when a simple cough becomes exuberating, it often calls for distinct attention which usually requires medical assistance. With this consideration in mind, it is then important to note what makes a cough extensively alarming and how it should be given proper attention to for the sake of imposing fast recovery on the patients being attended. For instance, the case of Chronic Obstructive Pulmonary Disease requires specific medical attention that usually involves both medication and respiratory therapy.
/>
In this presentation, a concentration on how ECOPD affects a patient and how such effect could be mandated accordingly shall be given further attention to. The resulting diagnosis on the case is expected to create a more defined pattern of resolution that could be applied to patients suffering from the said ailment.
Background of Ailment
Observed to have developed accordingly from the emergence of environmental pollutants, ECOPD is a much serious condition of a common cough that is often characterized by increased hyperinflation of the respiratory tract thus making it hard for the patient to breath. The infection in the respiratory tract often creates irritating results making it harder for the patients to incur particular points of progress even amidst drinking medicine particularly dedicated towards treating the symptoms of their COPD health case.
Individuals with COPD are often endangered to be further developing a more complex respiratory case especially that the ailment is strongly affected by external elements such as environmental pollutants. The containment of the situation and the environment where COPD patients are situated is then expected to be practically determined for the sake of improving the recovery process of the said individuals. The process of medication and treatment dedicated to such aspect of health needs constant and direct attention from medical practitioners who are to attend to the diagnosed patients accordingly.
Risk Factors
When it comes to developing ECOPD, the real risk of the matter relies on the idea by which the patient becomes prone to breathlessness thus imposing that the patient needs to deal with specific points of respiratory restrictions that may be more than just irritating. The concentration of medications dedicated for the patient to consider may not be that easy to flush out in the end; this particular matter risks the integrity of the liver in filtering out unnecessary substances that may harm the body later on. Medical practitioners though try to make sure that the dosage of the medication that is provided for the patients be controlled enough thus hopefully does not cause any particular damage to the patient’s physical system.
There is also the risk of not reporting the condition to the doctor at an earlier stage. Patients developing ECOPD often mistakenly see it as a mere indication of a bad cough. Nevertheless, it is often the determination of an irregularity in such system [which has not been detected early on] that causes severe problems later on. The capacity of the medical practitioners to attend to such cases as immediate as necessary may help resolve the problem accordingly. However for those who continuously consider such matter as rather simple and common as it is with a common cough, resolving the situation may be harder to obtain.
Causes and Symptoms
Most often than not, the primary cause of ECOPD is an underlying course of a series of common coughs occurring at one time [for a long time]. Neglecting the onset of such situation has caused many patients more time and money spend on reducing the symptoms of ECOPD that they may have incurred through a long period of exposure to pollutants in the environment that they are thriving in. Practically, due to not considering the matter to be anything more than serious, there are patients who simply set everything aside until the case becomes harder to contend with.
Other visual representations of the symptoms of the ailment include swollen feet and other inflammation of other parts of the body due to the massive response of the system to fight off the virus that has infected the respiratory tract. Another remarkable syndrome among patients developing ECOPD is that of the lowered level of their endurance to the different activities they are in need of completing in a day. In fact, there are times when patients of EOCPD feel the effect of exhaustion therefore putting them in a state of constant exhaustion even from doing rather common and very light activities at home, at school or at work.
If the patient did start gradually from the development of COPD, there are chances that the development of the ailment would be gradual as well. Hence, when this situation happens, it often becomes impossible for both the patients and the medical attendees to come together to complete a specific course of treatments. Nevertheless, resolutions through therapies and medical assistance programs have already been designed to answer the reasons behind the degenerating physical [and at times, mental capacity of a person] state of the patient. It is with this particular fact that treatments even for the very common and abrupt onset of such ailment is being considered accordingly.
Some of the severe symptoms that patients may experience include the inability to breathe even when completing common regular tasks like walking and talking. Other manifestations include confusion and a distinct course of sleepiness, often suggesting depression among the said individuals who have settled for such response in the public regarding their case and their situation. Another symptom would be the development of rapid heart rate in the patient. This is often caused by the inability of the respiratory system to support its natural function, thus making it harder for the heart to pump out blood as needed. These common functions are relatively affected by the emergence of ECOPD among patients especially if they already have underlying courses of other ailments that they need to battle with.
Diagnosis
There are several tests that are run to examine if a patient does have an ECOPD or is at least at risk in developing such ailment. Practically, general check-ups do create a definite course of determining the condition by which a patient might develop ECOPD. The regular common-health workup among patients of COPD helps medical attendees to become more cautious and alert about the condition of their patients through keeping record of their developments and other notes on their health situation through the different times of their visits for checkups or during the times of their admission to healthcare facilities such as hospitals. These recorded information could be used for analysis later on especially in utilizing historical note on how much possible it is for an individual to develop ECOPD.
Testing patient samples for laboratory analysis has also become a common ground for developing a more definite course of improvement in understanding whether or not a patient has high risk of developing ECOPD [if he is not diagnosed with such condition yet]. Aside from lab tests, a chest x-ray may also be required by healthcare attendee from the patient, especially for the sake of looking for the path that the sputum thickening takes into account.
General Treatments
The primary concern of medical practitioners in handling cases of ECOPD is that of the fact that the patient needs to be prepared for other symptoms that might come along their way. The main point of recovery first begins with the elimination of the symptom of breathlessness among patients. To do this, inhalers may be used to ease put the air passage way for the patients. Bronchilators are also used to make sure that the lungs would have better and more open passage ways. Oxygen therapy is also a promising course of response to being sick which is medication. It is important that the patient respond fully to whatever process of medical attention may be imposed on him; to be able to make sure on such matter, the compatibility of the patient towards specific healthcare operations would be necessary to take notice of.
Antibiotics are also prescribed to ease out the hold of the bacteria into the system of the patient. Usually, since the target age of such ailment is between 65 onwards, it could be understood while the extra care is required. Patients who have become accustomed to such matter could be managed more effectively; although it is highly recommended that the senior citizens be helped out fully with regards the incurring of ECOPD and the possibility of developing a more relative process of resolving the issue at hand.
Reducing inflammation in the passage airway is important as this will clear off the palpitations and the breathlessness accordingly. If the ailment strikes an old individual, it is highly important that the patients be given the chance to understand their situation. Doing so shall lessen the tension among the patient and their loved ones especially when it comes to deciding who will have a more dedicated time and attention for those who are in need of assistance, especially relating to the issues related to ECOPD that may be cured accordingly.
References
Rabe KF, Hurd S, Anzueto A, et al. (2007). "Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary". Am. J. Respir. Crit. Care Med. 176 (6): 532–55. doi:10.1164/rccm.200703-456SO. PMID 17507545.
Uppsala Academic Hospital > Guidelines for treatment of acute lung diseases. August 2004. Authors: Christer Hanson, Carl-Axel Karlsson, Mary Kämpe, Kristina Lamberg, Eva Lindberg, Lavinia Machado Boman, Gunnemar Stålenheim
Calverley PM, Anderson JA, Celli B, et al. (2007). "Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease". N. Engl. J. Med. 356 (8): 775–89.
Tashkin DP, Celli B, Senn S, et al. (October 2008). "A 4-year trial of tiotropium in chronic obstructive pulmonary disease". The New England Journal of Medicine 359 (15): 1543–54.
Zhou Y, Wang X, Zeng X, et al. (2006). "Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year". Respirology 11 (5): 603–10.
Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK (2000). "Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial". BMJ 320 (7245): 1297–303.
Austin MA, Wills KE, Blizzard L, Walters EH, Wood-Baker R (2010). "Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial". BMJ 341: c5462.
Bach PB, Brown C, Gelfand SE, McCrory DC (2001). "Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence". Ann. Intern. Med. 134 (7): 600–20.
Jump up ^ Lindenauer PK, Pekow PS, Lahti MC, Lee Y, Benjamin EM, Rothberg MB (June 2010). "Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease". JAMA 303 (23): 2359–67. doi:10.1001/jama.2010.796. PMID 20551406.
Gibson, et al. Evidence-based Respiratory Medicine. Blackwell Publishing, 2005. pp. 390-392.
Quon BS, Gan WQ, Sin DD (March 2008). "Contemporary management of acute exacerbations of COPD: a systematic review and metaanalysis". Chest 133 (3): 756–66.
